Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 127,431,318	$ 125,044,092
Inventories	1,677,668	1,494,891
Finance lease receivables, current - related parties	9,757,901	5,992,585
Income tax recoverable	841,677	0
Customer loans receivable, current	11,593,195	10,382,537
Prepaid expenses and other current assets	14,707,082	11,276,802
Total current assets	227,203,222	184,451,020
Non-current assets:
Property and equipment, net	6,995,263	8,771,902
Intangible assets, net	23,302,796	1,590,052
Goodwill, net	4,924,699	4,613,784
Cryptocurrencies	570,286	0
Finance lease receivables, non-current - related parties	14,709,715	8,397,582
Operating lease right-of-use assets	4,886,486	5,267,056
Finance lease right-of-use assets	478,742	0
Deferred tax assets	607,731	9,798,071
Customer loans receivable, non-current	6,553,611	5,023,551
Long-term prepayments	396,242	1,745,801
Other assets	7,256,463	15,553,453
Total non-current assets	94,159,863	81,632,134
Total assets	321,363,085	266,083,154
Current liabilities:
Current portion of long-term loans	3,044,470	96,824
Notes and other payables, current - related parties	1,637,370	26,255
Income tax payable	766,796	18,705,851
Operating lease liabilities, current	3,545,667	4,341,522
Finance lease liabilities, current	147,603	0
Accrued liabilities and other current liabilities	4,561,978	8,103,194
Total current liabilities	44,584,834	61,191,890
Non-current liabilities:
Long-term loans	18,078,324	6,502,682
Notes and other payables, non-current - related parties	0	5,334
Deferred tax liabilities	7,769,090	926,023
Operating lease liabilities, non-current	1,564,370	1,241,526
Finance lease liabilities, non- current portion	136,677	0
Other liabilities	1,170,589	1,193,541
Total non-current liabilities	28,719,050	9,869,106
Total liabilities	73,303,884	71,060,996
Stockholders’ equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of September 30, 2025 and December 31, 2024)	0	0
Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,881,251 and 103,020,816 shares issued, 102,576,943 and 102,750,816 shares outstanding as of September 30, 2025 and December 31, 2024, respectively)	10,388	10,302
Additional paid in capital	72,196,114	62,513,923
Treasury stock (at cost, 1,304,308 and 270,000 shares as of September 30, 2025 and December 31, 2024, respectively)	(7,749,997)	(2,700,000)
Retained earnings	226,248,329	189,463,007
Accumulated other comprehensive loss	(42,716,542)	(54,178,075)
Total SBC Medical Group Holdings Incorporated stockholders’ equity	247,988,292	195,109,157
Non-controlling interests	70,909	(86,999)
Total stockholders' equity	248,059,201	195,022,158
Total liabilities and stockholders’ equity	321,363,085	266,083,154
Nonrelated Party [Member]
Current assets:
Accounts receivable	2,609,108	1,413,433
Non-current assets:
Long-term investments, net	4,608,439	3,049,972
Current liabilities:
Accounts payable	17,258,372	13,875,179
Advances from customers	1,030,416	820,898
Related Party [Member]
Current assets:
Accounts receivable	58,585,273	28,846,680
Non-current assets:
Long-term investments, net	18,869,390	17,820,910
Current liabilities:
Accounts payable	2,842,877	659,044
Advances from customers	6,957,477	11,739,533
Due to related party	$ 2,791,808	$ 2,823,590

SBC Medical Group Holdings Inc 10-Q